The respective number of RSUs available for grant under the 2021 RSU Plan was 10,434,474 on 1 January 2022 and 10,483,774 on 31 December 2022. The number of shares that may be issued in respect of options and R
24. As of July 31, there were 12 tentative approvals for Vyvanse generics, with some issued as early as 2014 and others as recently as June 14, 2023. Companies looking to market these generics include Teva, Mylan and Sandoz. Tu predicted that the breadth of Takeda’s portfolio would ...
Trademarks, trade names or service marks of other companies appearing on this press release are the property of their respective owners.Forward-Looking StatementsThis press release will contain certain "forward-looking" statements as that term is defined in the Private Securities Litigation Reform Act ...